18/10000 18/10000 real-time translation of Sepsis combined with acute respiratory distress syndrome Sepsis combined with acute respiratory distress syndrome
Conditions
Interventions
Experimental group:conventional Western Medicine therapy and fusu mixture
Control group:conventional Western Medicine therapy and placebo
Sponsors
Hospital of Chengdu University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: (1) Age = 18 years old; (2) Complies with the 2023 ARDS guidelines and the 2016 Sepsis3.0 diagnostic criteria; and complies with the "cold transformation syndrome of Shaoyin"; (3) Expected hospitalization time = 7 days; (4) Sign the informed consent form; Note: Only those who meet the above four criteria can be included.
Exclusion criteria
Exclusion criteria: (1) Those who may die within 24 hours; (2) Patients with severe illness requiring cardiopulmonary resuscitation; (3) Late stage malignant tumors with cachexia; (4) Individuals who are allergic to the the components of the fusu mixture or have an allergic constitution; (5) Pregnant women; (6) Participated in other clinical trials in the past 3 months; (7) Expected offline difficulties; (8) Clinical researchers believe that there are other circumstances that are not suitable for participation in the study. Note: Any of the above criteria must be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of days without mechanical ventilation in 28 day surviving patients; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood gas analysis;breathe;white blood cell;clinical pulmonary infection score;Procalcitonin;Heart rate;Chest CT;extravascular lung water index;CRP;ECG;Temperature;IL-6;ICU length of stay;TNF-a;t-lymphocyte subset;SOFA;Apache-II;28 day and 90 day all-cause mortality rates;Blood pressure; | — |
Countries
China
Contacts
Public ContactXiujuan Zhou
Hospital of Chengdu University of Traditional Chinese Medicine
Outcome results
None listed